
Miguel
Alcoceba Sánchez
Researcher from 2011
Publications (110) Miguel Alcoceba Sánchez publications
filter_list
2025
-
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia
American Journal of Hematology
-
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL
HemaSphere, Vol. 9, Núm. 1
-
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)
Medicina Clinica
2024
-
Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
HLA, Vol. 104, Núm. 2
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
British Journal of Haematology, Vol. 205, Núm. 1, pp. 109-121
-
Quantifying HLA Mismatches at Epitope Level in Haplo-HSCT: Impact in the Outcome in Strategies Using PTCy
HLA, Vol. 104, Núm. 5
-
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient
Biomedicines, Vol. 12, Núm. 1
-
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
HemaSphere, Vol. 8, Núm. 10
-
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
HemaSphere
2023
-
An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3’ Untranslated Region of RRAS2 Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients
Cancers, Vol. 15, Núm. 3
-
Characterization of Three Somatic Mutations in the 3′UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia
Cells, Vol. 12, Núm. 23
-
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level
Disease models & mechanisms, Vol. 16, Núm. 8
-
Detection and characterization of the novel HLA-DPA1*02:66:02N allele, with a premature stop codon in exon 2
Human Immunology, Vol. 84, Núm. 4, pp. 296-300
-
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
International Journal of Molecular Sciences, Vol. 24, Núm. 9, pp. 8005
-
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
Blood Advances
-
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
eClinicalMedicine, Vol. 65
-
Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation
American Journal of Dermatopathology, Vol. 45, Núm. 6, pp. 378-382
-
Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
Cancers, Vol. 15, Núm. 3
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Blood Advances, Vol. 7, Núm. 14, pp. 3695-3709
2022
-
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
Blood Advances, Vol. 6, Núm. 21, pp. 5763-5773